HLA compatible red cell transfusion. This will be a personalised form of standard of care blood transfusion (as per Australian Patient Blood Management Guidelines), in which the blood donor will be selected to maximise HLA compatibility with the recipient. Selection will involve comparing the donor and recipient HLA types and choosing a donor who is matched as closely as possible with the recipient by HLA antigens and/or by epitope based methods. The red cells will also be irradiated, as is stan
Sponsors
Australian Red Cross Blood Service
Unknown Phase
HAbIT Part 1: Incidence of new Human leucocyte antigen (HLA) Antibody formation after Transfusion with blood products in patients with end stage kidney disease who are planned for live donor kidney transplant: A prospective study
CompletedACTRN12618000264280
Start: 2019-11-06End: 2023-12-20Target: 120Updated: 2024-04-15
HAbIT Part 3: Human Leukocyte Antigen (HLA) antibodies after red cell transfusion- a randomised controlled trial
CompletedACTRN12619000163101
Start: 2020-10-26End: 2023-04-11Target: 150Updated: 2023-09-04